logo

Concord Biotech Ltd. Financials

15:58 Sep 12

Concord Biotech Ltd.

Sector Pharmaceuticals & Biotechnology Industry Biotechnology
Up
1639.00
+0.20 (+0.01%)
Sector Pharmaceuticals & Biotechnology Industry Biotechnology

Concord Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Up
1639.00
+0.20 (+0.01%)
15:58 Sep 12
Quality
image/svg+xml

64/100
High Financial Strength

Valuation
image/svg+xml

28/100
Expensive Valuation

Technical

36/100
Technically Neutral

Strength

7

Weakness

8

Opportunity

0

Threats

1

20.50 %

ROE %

18.26 %

ROA %

34.04

EPS

173.27

BVPS

30.96 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
712.93 853.17 1016.94 1200.09 1188.27
Operating Expenses +
439.66 509.88 585.39 693.76 701.83
Raw Material
187.99 195.84 241.28 320.3 326.25
Increase Decrease in Cost
-23.98 -15.63 -12.08 -14.79 -23.93
Other Manufacturing Expense
0 0 0 0 55.78
Employee Cost
95.69 110.28 123.05 138.93 145.17
Miscellaneous Expenses
241.42 276.93 346.62 361.3 198.56
Operating Profit
273.27 343.29 431.55 506.33 486.44
Other Income
23.42 35.31 33.78 44.45 47.82
Depreciation
50.05 54.03 53.59 54.37 58.97
Interest
5.48 4.51 2.55 0.53 0.36
Profit before tax and exceptio..
241.16 320.05 409.19 495.88 474.93
Exceptional Items
0 0 0 0 0
PBT
241.16 320.05 409.19 495.88 474.93
Provision for Taxation
62.59 81.93 104.46 122.91 117.65
Net Profit
178.57 238.13 304.73 372.96 357.3
NET Profit after MI
174.93 240.09 308.1 371.64 356.11
EPS
16.72 22.95 29.45 35.52 34.04
Operating Profit Margin (%)
38.33 40.24 42.44 42.19 40.94
Net Profit Margin (%)
24.54 28.14 30.3 30.97 29.97

Concord Biotech Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Jun 25 Mar 25 Dec 24 Sep 24 Jun 24
Promoter 44.10 44.10 44.10 44.10 44.10
FII 9.10 9.40 8.30 8.10 7.10
MF 4.70 5.20 4.90 5.00 5.30
Others 4.20 3.90 4.80 4.80 5.10
Shareholder Shares Holding %
Research 360 logo
Download Our App On: